Quilizumab (IGHE) - Research Grade Biosimilar
Product Specifications
Background
Quilizumab is under investigation in clinical trial NCT01160861 (A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis) .
Immunogen
Humanized / IGHE [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
47H4, Anti-M1 prime, MEMP1972A, RG-7449
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742853-100 1x 100 µL
CD54 / ICAM-1 (15.2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881081-100 1x 100 µL
CD45RO (190-2F2.5), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940017-500 1x 500 µL
Ep-CAM / CD326 (VU-1D9), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740017-100 1x 100 µL
Ep-CAM / CD326 (VU-1D9), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400679-500 1x 500 µL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details